BACKGROUND: The purpose is to determine the clinicopathologic factors related to survival and recurrence of primary resected @entity242 (STS). METHODS: Demographic/clinical variables were recorded. RESULTS: Thirty-five pts were identified. Median follow-up was 24.2 months. There were 23 (65.7%) high/intermediate-grade and 12 (34.3%) low-grade @entity5 included in the final analysis. Eight @entity1 (22.9%) received neoadjuvant therapy. Margins were grossly negative in 27 (77.1%, 17-R0, 10-R1) and grossly positive (R2) in 8 (22.9%). Adjuvant therapy was used in 13 @entity1 (37.1%). The 2- and 3-year @entity4434 was 56.5% and 51.3%, with 14 @entity1 recurring at a median time of 16 months (6-local, 8-distant). All distant recurrences were in high-grade @entity5 . There were no differences in @entity4434 for margins (R0 vs. R1), neoadjuvant/adjuvant therapy, size (>= 10 vs. <10   cm) or gender. High/intermediate-grade @entity5 had worse @entity4434 (P   <   0.008). The 2- and 3-year @entity3012 was 80.9%. @entity3012 was improved for R0/R1 resection (P   <   0.001). Resection to R0/R1 margin was a significant predictor of improved @entity3012 (P   =   0.001). CONCLUSIONS: High/intermediate-grade lesions were associated with worse @entity3012 and @entity4434 . Resection to gross negative margins was the only independent predictor of @entity3012 . Adjuvant therapy may be reserved for high-grade lesions due to increased metastatic potential. J. Surg. Oncol.    2015 Wiley Periodicals, Inc.

Recurrence and survival analysis of resected soft tissue XXXX of pelvic retroperitoneal structures.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity242 :: ('MESH:D012509', 'Disease') :: ['pelvic soft tissue sarcomas'] @entity3012 :: ('MESH:C567932', 'Disease') :: ['OS'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumors'] @entity4434 :: ('MESH:D005198', 'Disease') :: ['RFS']
@entity242 :: (MESH:D012509,Disease) :: ['sarcomas']
